DexCom, Inc. (DXCM)
NASDAQ: DXCM · Real-Time Price · USD
80.24
+0.70 (0.88%)
At close: Dec 24, 2024, 1:00 PM
80.18
-0.06 (-0.07%)
After-hours: Dec 24, 2024, 1:45 PM EST
DexCom Stock Forecast
Stock Price Forecast
The 17 analysts with 12-month price forecasts for DexCom stock have an average target of 98, with a low estimate of 75 and a high estimate of 130. The average target predicts an increase of 22.13% from the current stock price of 80.24.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for DexCom stock from 17 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
---|---|---|---|---|---|---|
Strong Buy | 6 | 6 | 6 | 6 | 6 | 6 |
Buy | 6 | 6 | 6 | 6 | 6 | 6 |
Hold | 5 | 5 | 5 | 5 | 5 | 5 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 17 | 17 | 17 | 17 | 17 | 17 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Citigroup | Citigroup | Strong Buy Maintains $85 → $91 | Strong Buy | Maintains | $85 → $91 | +13.41% | Dec 11, 2024 |
Wells Fargo | Wells Fargo | Buy Maintains $90 → $94 | Buy | Maintains | $90 → $94 | +17.15% | Dec 11, 2024 |
Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $89 → $99 | Strong Buy | Maintains | $89 → $99 | +23.38% | Dec 9, 2024 |
Bernstein | Bernstein | Buy Maintains $82 → $86 | Buy | Maintains | $82 → $86 | +7.18% | Oct 25, 2024 |
Raymond James | Raymond James | Strong Buy Maintains $115 → $99 | Strong Buy | Maintains | $115 → $99 | +23.38% | Oct 25, 2024 |
Financial Forecast
Revenue This Year
4.10B
from 3.62B
Increased by 13.10%
Revenue Next Year
4.70B
from 4.10B
Increased by 14.74%
EPS This Year
1.74
from 1.30
Increased by 33.70%
EPS Next Year
2.07
from 1.74
Increased by 18.77%
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | 4.2B | 5.0B | 5.9B | |||
Avg | 4.1B | 4.7B | 5.4B | |||
Low | 3.9B | 4.4B | 4.8B |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | 16.9% | 21.2% | 25.8% | |||
Avg | 13.1% | 14.7% | 15.2% | |||
Low | 8.1% | 7.2% | 2.9% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | 1.83 | 2.33 | 3.02 | |||
Avg | 1.74 | 2.07 | 2.52 | |||
Low | 1.62 | 1.85 | 2.21 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | 40.3% | 33.7% | 46.2% | |||
Avg | 33.7% | 18.8% | 21.8% | |||
Low | 24.2% | 6.3% | 7.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.